Burkitt Lymphoma Update

INCTR’s project on the treatment of Burkitt lymphoma has now accrued over 750 patients on study. When last analyzed the long term survival rate of all patients was in access of 60%, although rates from individual centers varied from a low of 40% to a high of 70%. The most recently added patients (2015) are currently being analyzed with the intent to publish a second paper from a single center (St Mary’s Hospital, Lacor).